{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:29:40Z","timestamp":1794324580741,"version":"4.9.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejmg.2021.104339","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T11:37:55Z","timestamp":1630928275000},"page":"104339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical-genetic characteristics and treatment outcomes of Turkish children with Gaucher disease type 1 and type 3: A sixteen year single-center experience"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-9789","authenticated-orcid":false,"given":"Ersin","family":"Gumus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuman Nur","family":"Karhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1181-7393","authenticated-orcid":false,"given":"Hayriye","family":"Hizarcioglu-Gulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inci Nur","family":"Saltik Temizel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Dokmeci (Emre)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Yuce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2021.104339_bib1","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1097\/MPH.0000000000000297","article-title":"Mesenteric and mediastinal lymphadenopathy in Egyptian children with gaucher disease types 1 and 3 treated with enzyme replacement therapy","volume":"37","author":"Abdelwahab","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104339_bib2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104339_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10545-014-9693-8","article-title":"Long-term effectiveness of enzyme replacement therapy in children with Gaucher disease: results from the NCS-LSD cohort study","volume":"37","author":"Anderson","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104339_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1542\/peds.2007-2144","article-title":"Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1","volume":"122","author":"Andersson","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ejmg.2021.104339_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13023-017-0627-z","article-title":"Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease","volume":"12","author":"Andrade-Campos","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104339_bib6","first-page":"499","article-title":"Outcome of enzyme replacement therapy in Turkish patients with Gaucher disease: does late intervention affect the response?","volume":"53","author":"Arikan-Ayyildiz","year":"2011","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.ejmg.2021.104339_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bcmd.2016.10.008","article-title":"Management goals for type 1 Gaucher disease: an expert consensus document from the European working group on Gaucher disease","volume":"68","author":"Biegstraaten","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ejmg.2021.104339_bib8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcmd.2016.10.014","article-title":"Treatment patterns from 647 patients with gaucher disease: an analysis from the gaucher outcome survey","volume":"68","author":"Deegan","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104339_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpeds.2007.02.057","article-title":"Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease","volume":"151","author":"Drelichman","year":"2007","journal-title":"J. Pediatr."},{"issue":"1\u20132","key":"10.1016\/j.ejmg.2021.104339_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ymgme.2016.12.001","article-title":"Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry","volume":"120","author":"El-Beshlawy","year":"2017","journal-title":"Mol. Genet. Metabol."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104339_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7863\/jum.1997.16.3.209","article-title":"Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurements","volume":"16","author":"Elstein","year":"1997","journal-title":"J. Ultrasound Med."},{"key":"10.1016\/j.ejmg.2021.104339_bib12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bcmd.2016.12.009","article-title":"Children with type 1 Gaucher disease: changing profiles in the 21st century","volume":"68","author":"Elstein","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104339_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmg.2008.02.004","article-title":"Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene","volume":"51","author":"Emre","year":"2008","journal-title":"Eur. J. Med. Genet."},{"issue":"5","key":"10.1016\/j.ejmg.2021.104339_bib14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4318\/tjg.2011.0244","article-title":"Pediatric gaucher experience in south marmara region of Turkey","volume":"22","author":"Erdemir","year":"2011","journal-title":"Turk. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104339_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bcmd.2007.09.008","article-title":"Rapid screening of 10 common mutations in Turkish Gaucher patients using electronic DNA microarray","volume":"40","author":"Ezgu","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ejmg.2021.104339_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcmd.2016.10.026","article-title":"Clinical and molecular characteristics of patients with Gaucher disease in Southern China","volume":"68","author":"Feng","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104339_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/ppul.24544","article-title":"Pulmonary manifestations in young Gaucher disease patients: phenotype-genotype correlation and radiological findings","volume":"55","author":"Gawad Tantawy","year":"2020","journal-title":"Pediatr. Pulmonol."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104339_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","article-title":"Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3","volume":"143","author":"Goker-Alpan","year":"2003","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104339_bib42","doi-asserted-by":"crossref","first-page":"708","DOI":"10.24953\/turkjped.2021.04.020","article-title":"A very rare cause of protein losing enteropathy: Gaucher disease","volume":"63","author":"Goktas","year":"2021","journal-title":"Turk J Pediatr."},{"issue":"Suppl. 1","key":"10.1016\/j.ejmg.2021.104339_bib19","first-page":"S12","article-title":"Gaucher disease types 1 and 3: phenotypic characterization of large populations from the ICGG Gaucher Registry","volume":"90","author":"Grabowski","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104339_bib20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2141.2012.09175.x","article-title":"Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years","volume":"158","author":"Hollak","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104339_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpedi.160.6.603","article-title":"The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis","volume":"160","author":"Kaplan","year":"2006","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"9\u201310","key":"10.1016\/j.ejmg.2021.104339_bib22","first-page":"957","article-title":"Analysis of the beta-glucocerebrosidase gene in Turkish Gaucher disease patients: mutation profile and description of a novel mutant allele","volume":"25","author":"Karaca","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104339_bib23","first-page":"158","article-title":"Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and\/or enzyme replacement therapy","volume":"2","author":"Kauli","year":"2000","journal-title":"Isr. Med. Assoc. J."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104339_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ymgme.2019.05.011","article-title":"Gaucher disease type 3c: new patients with unique presentations and review of the literature","volume":"127","author":"Kurolap","year":"2019","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejmg.2021.104339_bib25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ymgme.2011.12.010","article-title":"Progressive mesenteric lymphadenopathy with protein-losing enteropathy; a devastating complication in Gaucher disease","volume":"105","author":"Lee","year":"2012","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejmg.2021.104339_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcmd.2016.11.014","article-title":"Growth and final height of children with Gaucher disease: a 15-year follow-up at an Israeli Gaucher center","volume":"68","author":"Mendelsohn","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ejmg.2021.104339_bib27","first-page":"13","article-title":"Successful therapy for protein-losing enteropathy caused by chronic neuronopathic Gaucher disease","volume":"6","author":"Mhanni","year":"2016","journal-title":"Mol Genet Metab Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.ejmg.2021.104339_bib28","first-page":"S6","article-title":"Understanding the natural history of Gaucher disease","volume":"90","author":"Mistry","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejmg.2021.104339_bib29","doi-asserted-by":"crossref","first-page":"100725","DOI":"10.1016\/j.mgene.2020.100725","article-title":"Molecular genetic analysis of Turkish Gaucher's disease patients reveals three novel variants in Glucocerebrosidase (GBA) gene","volume":"25","author":"Onal","year":"2020","journal-title":"Meta Gene"},{"issue":"4 Suppl. 5","key":"10.1016\/j.ejmg.2021.104339_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ejmg.2021.104339_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CE.S93717","article-title":"Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy","volume":"11","author":"Serratrice","year":"2016","journal-title":"Core Evid."},{"key":"10.1016\/j.ejmg.2021.104339_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1750-1172-7-77","article-title":"The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients","volume":"7","author":"Stirnemann","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104339_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104339_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients","volume":"84","author":"Taddei","year":"2009","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104339_bib35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ymgme.2009.05.001","article-title":"Clinical and genetic study of Japanese patients with type 3 Gaucher disease","volume":"97","author":"Tajima","year":"2009","journal-title":"Mol. Genet. Metabol."},{"issue":"4","key":"10.1016\/j.ejmg.2021.104339_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic gaucher disease: demographic and clinical features of 131 patients enrolled in the international collaborative gaucher group neurological outcomes subregistry","volume":"33","author":"Tylki-Szymanska","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104339_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bcmd.2006.02.001","article-title":"Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations","volume":"36","author":"Wan","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.ejmg.2021.104339_bib38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10545-012-9528-4","article-title":"Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment","volume":"36","author":"Weinreb","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"10.1016\/j.ejmg.2021.104339_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/pbc.21948","article-title":"Giant lymphadenopathy infiltrated by gaucher cells mimicking lymphoma","volume":"52","author":"Yagci","year":"2009","journal-title":"Pediatr. Blood Canc."},{"issue":"6","key":"10.1016\/j.ejmg.2021.104339_bib40","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/gim.2016.159","article-title":"Early manifestations of type 1 Gaucher disease in presymptomatic children diagnosed after parental carrier screening","volume":"19","author":"Yang","year":"2017","journal-title":"Genet. Med."},{"issue":"2","key":"10.1016\/j.ejmg.2021.104339_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.24957","article-title":"Demographics and patient characteristics of 1209 patients with gaucher disease: descriptive analysis from the gaucher outcome survey (GOS)","volume":"93","author":"Zimran","year":"2018","journal-title":"Am. J. Hematol."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221002056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721221002056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:51:20Z","timestamp":1761709880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721221002056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1769721221002056"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104339","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical-genetic characteristics and treatment outcomes of Turkish children with Gaucher disease type 1 and type 3: A sixteen year single-center experience","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2021.104339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104339"}}